Primary dystonia misinterpreted as Parkinson disease
Video case presentation and practical clues
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published October 3, 2013.
Article Versions
- Previous version (October 3, 2013 - 13:36).
- You are viewing the most recent version of this article.
Author Disclosures
- Olga Klepitskaya, MD,
- Alexander J. Neuwelt, MD,
- Tam Nguyen, MD and
- Maureen Leehey, MD
- Olga Klepitskaya, MD,
NONE
NONE
has received compensation for travel to the investigator meeting from USWorldMeds and Ipsen Biopharmaceuticals
Brain Disorders and Therapy. Editorial board member
NONE
NONE
NONE
Medtronic Neuromodulation, Merz Pharmaceutical, TEVA Pharmaceuticals
NONE
NONE
performs botulinum toxin injections (10% clinical effort) and involved in Deep Brain Stimulation treatment of movement disorders (45% clinical effort)
Neurologix, Schwartz Biosciences, Impax Pharmaceuticals, Solstice Neurosciences, Biotie Therapies, Ipsen Biopharmaceuticals
NIH-NINDS
University of Colorado Denver, Department of Neurology, academic enrichment fund
NONE
NONE
NONE
NONE
NONE
NONE
has participated in a medical-legal cases.
- Alexander J. Neuwelt, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tam Nguyen, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Maureen Leehey, MD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Gerson Lehman
NONE
NONE
performs botulinum toxin injections (5% of effort)
funded as a site investigator in a multi-center trials funded from Neurologix, Inc. (2008 - 2011), Schwartz Biosciences, Inc. (2008- 2012), and Impax pharmaceuticals (2011-2012)
NINDS, 2U1-NS044479, site investigator, 2002-2015; NIA, 2007-2012, RL1 AG032115, site investigator
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Law office of Michael Goodman, PC, deposition, 2012; Amex Assurance Company, expert witness, 2012
- Correspondence to:
Olga.Klepitskaya{at}ucdenver.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.